Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.14%) $83.69
Gas
(-1.16%) $1.619
Gold
(0.28%) $2 349.00
Silver
(-0.48%) $27.22
Platinum
(0.36%) $923.80
USD/EUR
(0.36%) $0.935
USD/NOK
(0.76%) $11.04
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.25%) $91.94

Realtime updates for CanSino Biologics Inc. [688185.SS]

Exchange: SHH Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Upcoming Earnings Alert

Quarter results today
(bmo 2024-04-26)

Expected move: +/- 0.00%

Last Updated26 Apr 2024 @ 03:00
25% discount on Stockinvest.us - Use code: Podcast

2.69% CNY 49.30

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 03:00):

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N...

Stats
Today's Volume 1.38M
Average Volume 1.58M
Market Cap 6.40B
EPS CNY0 ( 2024-03-28 )
Last Dividend CNY0 ( N/A )
Next Dividend CNY0 ( N/A )
P/E -8.20
ATR14 CNY0.0480 (0.10%)

Volume Correlation

Long: 0.16 (neutral)
Short: -0.12 (neutral)
Signal:(59.659) Neutral

CanSino Biologics Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CanSino Biologics Inc. Correlation - Currency/Commodity

The country flag -0.39
( neutral )
The country flag -0.58
( weak negative )
The country flag 0.00
( neutral )
The country flag -0.08
( neutral )
The country flag -0.12
( neutral )
The country flag -0.47
( neutral )

CanSino Biologics Inc. Financials

Annual 2023
Revenue: CNY349.12M
Gross Profit: CNY-21.83M (-6.25 %)
EPS: CNY-6.01
FY 2023
Revenue: CNY349.12M
Gross Profit: CNY-21.83M (-6.25 %)
EPS: CNY-6.01
FY 2022
Revenue: CNY1.03B
Gross Profit: CNY-186.61M (-18.10 %)
EPS: CNY-3.91
FY 2021
Revenue: CNY4.30B
Gross Profit: CNY3.00B (69.85 %)
EPS: CNY7.74

Financial Reports:

No articles found.

CanSino Biologics Inc.

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It also develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. Further, the company develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. In addition, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CSB012 to treat adenovirus; CSB013 for ZIKA virus; CSB015 to treat meningitis; CSB016 for treating shingles; and CSB107 for polio. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators